Effects of Emotion-Focused Therapy (EFT) on Mood Awareness and Emotional Reactivity in Bipolar PatientsAwareness and Emotional Reactivity
Launched by MUĞLA SITKI KOÇMAN UNIVERSITY · Dec 3, 2024
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how Emotion-Focused Therapy (EFT) can help people with bipolar disorder improve their awareness of their feelings and manage their emotional reactions. Bipolar disorder is a serious condition that causes extreme mood swings, which can make it hard for individuals to stick to their treatment plans. By increasing mood awareness, patients may find it easier to cope with their emotions, follow their prescribed treatments, and live healthier lives.
To participate in this study, individuals need to be between 18 and 65 years old, have a diagnosis of bipolar disorder, and be receiving standard medication while in a stable phase of their condition. Participants will take part in six therapy sessions during their hospital stay, where they will learn to recognize and manage their emotions better. The study aims to see if this therapy can lead to better treatment adherence and improved overall functioning. If you're interested in participating, please know that your feelings and experiences will be carefully considered, and the team will support you throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Inclusion criteria are being between the ages of 18-65,
- • 2. Being diagnosed with Bipolar Disorder (I, II) and receiving maintenance treatment and being in remission,
- • 3. Receiving standard drug treatment (mood stabilizer, antipsychotic or antidepressant) and standard clinical follow-up for bipolar disorder,
- • 4. Not having hearing, comprehension and vision problems,
- • 5. Being able to read and write,
- • 6. Being patients who agree to participate in the study.
- Exclusion Criteria:
- • 1. Having another psychotic disorder in addition to the diagnosis of bipolar disorder,
- • 2. Being newly diagnosed with bipolar disorder and being in the acute phase,
- • 3. Wanting to leave the study,
- • 4. Not agreeing to participate in the study,
About Muğla Sıtkı Koçman University
Muğla Sıtkı Koçman University is a distinguished academic institution located in Turkey, committed to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust research infrastructure and expertise to facilitate high-quality clinical studies that aim to enhance medical knowledge and improve patient outcomes. With a focus on ethical practices and collaboration, Muğla Sıtkı Koçman University strives to contribute significantly to the scientific community through rigorous clinical research and development initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, Muğla, Turkey
Multiple Locations, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported